WNY Asset Management LLC bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, HoldingsChannel.com reports. The firm bought 10,678 shares of the company’s stock, valued at approximately $1,372,000.
Other institutional investors have also recently bought and sold shares of the company. Gables Capital Management Inc. bought a new position in shares of Merck KGaA in the second quarter worth about $2,095,000. Diversify Advisory Services LLC bought a new stake in shares of Merck KGaA during the 2nd quarter valued at approximately $3,810,000. Danske Bank A S acquired a new position in Merck KGaA during the 2nd quarter worth approximately $276,535,000. Danica Pension Livsforsikringsaktieselskab acquired a new stake in Merck KGaA in the second quarter valued at approximately $25,541,000. Finally, BOK Financial Private Wealth Inc. bought a new stake in shares of Merck KGaA during the second quarter worth $523,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Stock Down 3.9%
Shares of OTCMKTS:MKGAF opened at $158.15 on Friday. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company has a market capitalization of $20.44 billion, a PE ratio of 24.14 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The company has a fifty day moving average of $163.21 and a 200-day moving average of $148.95.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
